SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001144204-18-053473
Filing Date
2018-10-11
Accepted
2018-10-11 16:11:43
Documents
6

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY PROSPECTUS SUPPLEMENT tv504665-424b5.htm 424B5 447788
2 GRAPHIC lg_iovance-color.jpg GRAPHIC 84299
3 GRAPHIC tv504665_chrt-table1.jpg GRAPHIC 48279
4 GRAPHIC tv504665_chrt-table2.jpg GRAPHIC 74892
5 GRAPHIC tv504665_chrt-table3.jpg GRAPHIC 53111
6 GRAPHIC tv504665_chrt-table4.jpg GRAPHIC 76248
  Complete submission text file 0001144204-18-053473.txt   913820
Mailing Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070
Business Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070 6502607120
IOVANCE BIOTHERAPEUTICS, INC. (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-227241 | Film No.: 181118486
SIC: 2836 Biological Products, (No Diagnostic Substances)